Table 1 Baseline characteristics by 30-day survival status
From: High platelet-to-albumin ratio is associated with 30-day mortality in critically ill patients
Characteristic | Survivor group (n = 299) | Non-survivor group (n = 79) | p value |
|---|---|---|---|
Age, years | 68 (54,77) | 68 (48,76) | 0.464 |
Male (n, %) | 203 (67.89) | 58 (73.42) | 0.345 |
BMI (kg/m2) | 22.51 ± 0.38 | 23.11 ± 0.43 | 0.521 |
APACHE II | 19.26 ± 4.74 | 23.55 ± 5.30 | < 0.001 |
Underlying diseases | |||
Diabetes mellitus (n, %) | 87 (29.10) | 30 (37.97) | 0.129 |
Hypertension (n, %) | 135 (45.15) | 28 (35.44) | 0.121 |
Chronic obstructive pulmonary disease (n, %) | 23 (7.69) | 1 (1.27) | 0.037 |
Chronic renal insufficiency (n, %) | 35 (11.71) | 13 (16.46) | 0.259 |
Chronic cholecystitis (n, %) | 14 (4.68) | 3 (3.80) | 0.974 |
Admission diagnosis | |||
Pneumonia (n, %) | 63 (21.07) | 18 (22.80) | 0.731 |
Severe burn or trauma (n, %) | 43 (14.38) | 8 (10.12) | 0.330 |
Acute myocardial infarction (n, %) | 67 (22.41) | 22 (27.85) | 0.304 |
Sepsis (n, %) | 65 (21.74) | 20 (25.32) | 0.498 |
Mechanical ventilation (n, %) | 176 (58.86) | 52 (65.82) | 0.261 |
Vasoactive drug (n, %) | 110 (36.79) | 38 (48.10) | 0.067 |
Leucocytes count (109/L) | 12.74 (8.64, 17.75) | 10.37 (6.45, 16.19) | 0.026 |
Neutrophil count (109/L) | 10.48 (6.65, 15.49) | 8.74 (5.04, 14.22) | 0.040 |
Lymphocyte count (109/L) | 0.92 (0.50, 1.53) | 0.78 (0.43, 1.38) | 0.335 |
Eosinophil count (109/L) | 0.01 (0.00, 0.05) | 0.01 (0.00, 0.04) | 0.392 |
Hemoglobin (g/L) | 104.83 ± 29.69 | 98.63 ± 33.14 | 0.109 |
Platelet count (109/L) | 194 (114, 244) | 191 (126, 258) | 0.711 |
Albumin (g/L) | 33.42 ± 6.57 | 27.10 ± 6.80 | < 0.001 |
PAR | 5.43 (3.62, 7.30) | 6.79 (4.71, 10.94) | < 0.001 |